Withdrawal Phenomena Associated with Antidepressant and Antipsychotic Agents
The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
The withdrawal of heterocyclic antidepressants and antipsychotic agents can produce nausea, emesis, anorexia, diarrhoea, rhinorrhoea, diaphoresis, myalgias, paraesthesias, anxiety, agitation, restlessness and insomnia. The withdrawal of monoamine oxidase (MAO) inhibitors may result in severe anxiety, agitation, pressured speech, sleeplessness or drowsiness, hallucinations, cognitive impairment, delirium, suicidality and delusions of persecution. The withdrawal of antipsychotic agents may give rise to symptoms preceding the onset of psychosis. These potential harbingers of relapse include anxiety, agitation, restlessness and insomnia. The withdrawal phenomena reviewed are usually prevented by gradually reducing the total daily dosage of the pertinent drug. Antimuscarinic agents often alleviate the distress produced by the withdrawal of tricyclic antidepressants and antipsychotic agents. MAO inhibitor withdrawal syndromes may constitute medical emergencies. The prevention of the evolution of a MAO inhibitor withdrawal-precipitated syndrome is a high priority.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Slower tapering will provide more time for these neuroadaptations and are likely to diminish withdrawal severity 33,44,47 .”
From Tapering of SSRI treatment to mitigate withdrawal symptoms (2019) · cites this paper as [44]
In the citing paper
“The adjunct of cognitive behavioral therapy to a careful tapering schedule was found of limited value by Voshaar et al. [81]”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [81]
Citations
Cites
The Pharmacological Basis of Therapeutics
(1976) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/33.4.373a · Cited by 8,209
Presynaptic regulation of the release of catecholamines.
Langer, S. Z. (1980) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06843-7 · Cited by 1,490
Three-Year Outcomes for Maintenance Therapies in Recurrent Depression
Frank, E. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810240013002 · Cited by 1,297
PRE AND POSTSYNAPTIC RECEPTORS
Rees, D. (1976) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.39.10.1035 · Cited by 775
Snyder, S. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760130040006 · Cited by 472
Aghajanian, G. K., & VanderMaelen, C. P. (1982) · Science · doi:10.1126/science.6278591 · Cited by 431
Antidepressants and the Muscarinic Acetylcholine Receptor
Snyder, S. H. (1977) · Archives of General Psychiatry · doi:10.1001/archpsyc.1977.01770140126014 · Cited by 425
Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity
Kehr, W., Carlsson, A., Lindqvist, M., Magnusson, T., & Atack, C. (1972) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1972.tb09104.x · Cited by 417
Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism
MILLER, R. J., & HILEY, C. R. (1974) · Nature · doi:10.1038/248596a0 · Cited by 381
Sensitization to cocaine stimulation in mice
Shuster, L., Yu, G., & Bates, A. (1977) · Psychopharmacology · doi:10.1007/bf00439108 · Cited by 256
Cited by
Serotonin Reuptake Inhibitor Withdrawal
Coupland, N. J., Bell, C. J., & Potokar, J. P. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199610000-00003 · Cited by 303
Tapering of SSRI treatment to mitigate withdrawal symptoms
Horowitz, M. A., & Taylor, D. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30032-x · Cited by 280
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Keller, M. B. (1998) · JAMA · doi:10.1001/jama.280.19.1665 · Cited by 184
Senay, E. C., Adams, E. H., Geller, A., Inciardi, J. A., Muñoz, Á., Schnoll, S. H., WOODY, G. E., & Cicero, T. J. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00321-6 · Cited by 136
Metadata
- Authors
- Dilsaver, S. C.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- Corresponding author
- Dilsaver, Steven C.
- Venue
- Drug Safety
- Published
- 1994-02
- Volume
- 10
- Issue
- 2
- Pages
- 103-114
- ISSN
- 0114-5916 (ISSN-L)
- OpenAlex
- W2004881821
- Cited by
- 60
- References
- 80
- Citations by year
- 2026: 5 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 2 · 2012: 2
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Safety (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- drug withdrawal syndrome, antidepressants, antipsychotic drugs, heterocyclic antidepressants, monoamine oxidase inhibitors, tricyclic antidepressants, antipsychotic withdrawal, antimuscarinic agents, relapse prevention, gradual dose reduction
- MeSH terms
- Adult, Animals, Antidepressive Agents, Female, Humans, Male, Middle Aged, Substance Withdrawal Syndrome, Antipsychotic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Withdrawal Phenomena Associated with Antidepressant and Antipsychotic Agents. https://app.cochat.ai/papers/10.2165/00002018-199410020-00002
- The paper
- Dilsaver, S. C. (1994). Withdrawal Phenomena Associated with Antidepressant and Antipsychotic Agents. Drug Safety. https://doi.org/10.2165/00002018-199410020-00002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.